Jeff Michalski
Washington University in St. Louis
H-index: 93
North America-United States
Top articles of Jeff Michalski
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202 | European Urology Focus | Kimberley S Mak Molly Scannell Bryan James J Dignam William U Shipley Yue Lin | 2024/2/1 |
Safety Analyses of the Phase 3 VISION Trial of [177Lu] Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer | European Urology | Kim N Chi Andrew J Armstrong Bernd J Krause Ken Herrmann Kambiz Rahbar | 2024/1/6 |
PD42-11 DEVELOPMENT AND VALIDATION OF A MULTIMODAL ARTIFICIAL INTELLIGENCE (MMAI)-DERIVED DIGITAL PATHOLOGY-BASED BIOMARKER PREDICTING METASTASIS FOR RADICAL PROSTATECTOMY … | The Journal of Urology | Todd M Morgan Yi Ren Siyi Tang Wouter Zwerink Emmalyn Chen | 2024/5 |
Phase 3 KEYNOTE-992 study of pembrolizumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with muscle-invasive bladder cancer (MIBC). | Shilpa Gupta Yasuhisa Fujii Michiel Simon Van Der Heijden Andrew James Weickhardt Nicholas D James | 2024/2/1 | |
TREATMENT OF NON-METASTATIC MUSCLE-INVASIVE BLADDER CANCER: AUA/ASCO/SUO GUIDELINE (2017; Amended 2020, 2024) | Sam S Chang Bernard H Bochner Roger Chou Robert Dreicer Ashish M Kamat | 2024 | |
ACR–ACNM–ARS–ASTRO–SNMMI Practice Parameter for the Performance of Therapy With Radiopharmaceuticals | American Journal of Clinical Oncology | Paul E Wallner Don C Yoo Jeremy Calais Freddy E Escorcia Carina Mari Aparici | 2024/4/1 |
Intensification of ADT with enzalutamide in high-risk patients with biochemical relapse following radical prostatectomy undergoing salvage radiation: Initial results from RTOG … | Edwin Melencio Posadas Hiram Alberto Gay Joseph P Rodgers Todd Matthew Morgan Ying Xiao | 2024/2/1 | |
CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer | Clinical and Translational Radiation Oncology | Michael Waters Alex Price Eric Laugeman Lauren Henke Geoff Hugo | 2024/1/1 |
Effects of androgen deprivation therapy on prostate cancer outcomes according to competing event risk: secondary analysis of a phase 3 randomised trial | European Urology | Loren K Mell Stephanie L Pugh Christopher U Jones Tyler J Nelson Kaveh Zakeri | 2024/4/1 |
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial | European Urology Oncology | Ashley E Ross Jingbin Zhang Huei-Chung Huang Rikiya Yamashita Jessica Keim-Malpass | 2024/2/1 |
Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical Trial | JAMA oncology | Mark K Buyyounouski Stephanie L Pugh Ronald C Chen Mark J Mann Rajat J Kudchadker | 2024/3/14 |
Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer | Journal of Nuclear Medicine | Nadia Benabdallah Peng Lu Diane S Abou Hanwen Zhang David Ulmert | 2024/2/1 |
Handling Patient Emergencies During Radiopharmaceutical Therapy | Practical Radiation Oncology | Nichole M Maughan Jacqueline E Zoberi Jose L Garcia-Ramirez Jeff M Michalski Brian C Baumann | 2024/2/12 |
Impact of clinical factors on 18F-flotufolastat detection rates in men with recurrent prostate cancer: exploratory analysis of the phase 3 SPOTLIGHT Study | Advances in Radiation Oncology | Benjamin H Lowentritt Ashesh B Jani Brian T Helfand Edward M Uchio Michael A Morris | 2024/5/1 |
Bridging the Gap of Radiotherapy Treatment Planning Quality between High-Income, and Low-and Middle-Income Countries Using Knowledge-Based Planning | International Journal of Radiation Oncology, Biology, Physics | M Ixquiac FJ Reynoso M Schmidt TR Mazur T Zhao | 2023/10/1 |
Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation … | Practical radiation oncology | Lindsay L Puckett Mohammad Titi Ksenija Kujundzic Samantha L Dawes Elizabeth M Gore | 2023/9/1 |
Biochemical recurrence surrogacy for clinical outcomes after radiotherapy for adenocarcinoma of the prostate | Journal of Clinical Oncology | Soumyajit Roy Tahmineh Romero Jeff M Michalski Felix Y Feng Jason A Efstathiou | 2023/11/10 |
Dose-escalated radiotherapy alone or in combination with short-term androgen deprivation for intermediate-risk prostate cancer: results of a phase III multi-institutional trial | Journal of Clinical Oncology | Daniel J Krauss Theodore Karrison Alvaro A Martinez Gerard Morton Di Yan | 2023/6/10 |
Association of Brachytherapy Boost with Overall Survival for Gleason 9-10 Prostate Cancer: The Impact of Primary versus Secondary Pattern 5 | Brachytherapy | Sagar A Patel Brian Baumann Jeff Michalski Randall Brenneman Bill Zheng | 2023/5/1 |
Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): A Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Low or Intermediate Risk … | International Journal of Radiation Oncology, Biology, Physics | AJ Wisdom BY Yeap JM Michalski AL Zietman BC Baumann | 2023/10/1 |
Co-Authors
